NANOSTRING TECHNOLOGIES, INC.
NSTGUnited States
34 filed reports · 418 financial concepts
Latest figures
Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.
Latest fiscal year
Filed reports
34 reports · Jun 2015 to Sep 2023Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 26 | 4,045 | Jun 2015 to Sep 2023 |
| Annual · 10-KSEC EDGAR | 8 | 4,027 | Dec 2015 to Dec 2022 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2023 Q3 | 10-Q | 2023-09-30 | 2023-11-06 | 330 | Open |
| FY2023 Q2 | 10-Q | 2023-06-30 | 2023-08-03 | 182 | Open |
| FY2023 Q1 | 10-Q | 2023-03-31 | 2023-05-03 | 202 | Open |
| FY2022 | 10-K | 2022-12-31 | 2023-02-28 | 837 | Open |
| FY2022 Q3 | 10-Q | 2022-09-30 | 2022-11-07 | 165 | Open |
| FY2022 Q2 | 10-Q | 2022-06-30 | 2022-08-04 | 148 | Open |
| FY2022 Q1 | 10-Q | 2022-03-31 | 2022-05-10 | 147 | Open |
| FY2021 | 10-K | 2021-12-31 | 2022-03-01 | 481 | Open |
| FY2021 Q3 | 10-Q | 2021-09-30 | 2021-11-09 | 167 | Open |
| FY2021 Q2 | 10-Q | 2021-06-30 | 2021-08-05 | 146 | Open |
| FY2021 Q1 | 10-Q | 2021-03-31 | 2021-05-10 | 148 | Open |
| FY2020 | 10-K | 2020-12-31 | 2021-03-01 | 453 | Open |
Financial data
418 concepts · 8,072 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial415 concepts · 6,950 facts · Dec 2012 to Sep 2023
- Cash and cash equivalents at carrying value51 · Dec 2012 to Sep 2023
- Comprehensive income net of tax49 · Dec 2013 to Sep 2023
- Cost of revenue (US GAAP)49 · Dec 2013 to Sep 2023
- Costs and expenses49 · Dec 2013 to Sep 2023
- Investment income interest49 · Dec 2013 to Sep 2023
- Net income loss49 · Dec 2013 to Sep 2023
- Nonoperating income expense49 · Dec 2013 to Sep 2023
- Operating income loss49 · Dec 2013 to Sep 2023
- Other comprehensive income unrealized holding gain loss on securities arising during period net of tax49 · Dec 2013 to Sep 2023
- Other nonoperating income expense49 · Dec 2013 to Sep 2023
- Research and development expense49 · Dec 2013 to Sep 2023
- Selling general and administrative expense49 · Dec 2013 to Sep 2023
- Stockholders equity (US GAAP)48 · Dec 2012 to Sep 2023
- Allocated share based compensation expense47 · Dec 2013 to Sep 2023
- Depreciation depletion and amortization47 · Dec 2013 to Sep 2023
- Increase decrease in accounts payable47 · Dec 2013 to Sep 2023
- Increase decrease in accounts receivable47 · Dec 2013 to Sep 2023
- Increase decrease in accrued liabilities47 · Dec 2013 to Sep 2023
- Increase decrease in deferred revenue47 · Dec 2013 to Sep 2023
- Increase decrease in inventories47 · Dec 2013 to Sep 2023
- Increase decrease in prepaid deferred expense and other assets47 · Dec 2013 to Sep 2023
- Interest Accrued On Long Term Notes47 · Dec 2013 to Sep 2023
- Investment income net amortization of discount and premium47 · Dec 2013 to Sep 2023
- Payments to acquire property plant and equipment47 · Dec 2013 to Sep 2023
Product2 concepts · 898 facts · Dec 2016 to Sep 2023
- Revenue868 · Dec 2016 to Sep 2023
- Cost of revenue (US GAAP)30 · Dec 2019 to Sep 2023
Geography1 concept · 224 facts · Dec 2013 to Sep 2023
- Revenue224 · Dec 2013 to Sep 2023
Segments
1,122 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or servicesrt:ProductOrServiceAxis7 members · 730 facts
- Service revenue131 · Dec 2016 to Sep 2023
- Total product revenue121 · Dec 2016 to Sep 2023
- Instruments116 · Dec 2016 to Sep 2023
- Consumables114 · Dec 2016 to Sep 2023
- Collaboration revenue100 · Dec 2016 to Sep 2022
- Total product and service revenue100 · Dec 2016 to Dec 2022
- In vitro diagnostic kits48 · Dec 2016 to Dec 2019
Product or serviceus-gaap:ProductOrServiceAxis7 members · 168 facts
- Collaboration revenue24 · Mar 2017 to Sep 2018
- Consumables24 · Mar 2017 to Sep 2018
- Instruments24 · Mar 2017 to Sep 2018
- In vitro diagnostic kits24 · Mar 2017 to Sep 2018
- Service revenue24 · Mar 2017 to Sep 2018
- Total product and service revenue24 · Mar 2017 to Sep 2018
- Total product revenue24 · Mar 2017 to Sep 2018
Statement geographicalsrt:StatementGeographicalAxis5 members · 122 facts
- United States [Member]29 · Dec 2016 to Sep 2023
- Americas28 · Dec 2016 to Sep 2023
- Asia Pacific27 · Dec 2016 to Sep 2023
- Europe and Middle East24 · Dec 2016 to Sep 2023
- Europe & Middle East [Member]14 · Dec 2016 to Dec 2021
Statement geographicalus-gaap:StatementGeographicalAxis5 members · 102 facts
- Americas [Member]24 · Dec 2013 to Sep 2018
- Asia Pacific [Member]24 · Dec 2013 to Sep 2018
- Europe & Middle East [Member]24 · Dec 2013 to Sep 2018
- United States [Member]24 · Dec 2013 to Sep 2018
- Europe and Middle East6 · Mar 2017 to Sep 2018
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Ask about this company in your AI model
Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.
Use FactIQ to get the revenue, net income and operating income of NANOSTRING TECHNOLOGIES, INC. (NSTG) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 19, 2026) and refreshed every few hours.